BioLife Solutions, Inc. Payments of Stock Issuance Costs
BioLife Solutions, Inc. (BLFS) reported Payments of Stock Issuance Costs of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2025-03-03
- BioLife Solutions, Inc. payments of stock issuance costs for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. payments of stock issuance costs for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. payments of stock issuance costs for the quarter ending 2022-12-31 was $1.00K.
- BioLife Solutions, Inc. payments of stock issuance costs for the quarter ending 2022-09-30 was $54.00K, a 62.76% decline year-over-year.
- BioLife Solutions, Inc. payments of stock issuance costs for fiscal 2024 was $0.00.
- BioLife Solutions, Inc. payments of stock issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- BioLife Solutions, Inc. payments of stock issuance costs for fiscal 2022 was $131.00K, a 9.66% decline from fiscal 2021.
- BioLife Solutions, Inc. payments of stock issuance costs for fiscal 2021 was $145.00K.
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-03 | |||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $0.00 10-K · filed 2025-03-03 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | |||||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $1.00K derived: sum of 2 quarters · filed 2025-03-03 | $55.00K derived: sum of 3 quarters · filed 2025-03-03 | $81.00K derived: sum of 4 quarters · filed 2025-03-03 | ||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $55.00K derived: sum of 2 quarters · filed 2025-03-03 | $81.00K derived: sum of 3 quarters · filed 2025-03-03 | $131.00K 10-K · filed 2025-03-03 | ||
| 2022-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $80.00K derived: sum of 2 quarters · filed 2023-11-09 | $130.00K 10-Q · filed 2023-11-09 | $130.00K derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $76.00K 10-Q · filed 2022-08-09 | $76.00K derived: sum of 3 quarters · filed 2024-02-29 | $221.00K derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $50.00K 10-Q · filed 2023-05-11 | $50.00K derived: sum of 2 quarters · filed 2024-02-29 | $195.00K derived: sum of 3 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $145.00K derived: sum of 2 quarters · filed 2024-02-29 | $145.00K 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $145.00K 10-Q · filed 2022-11-09 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||||
| 2020-12-31 | -$6.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$6.20M derived: sum of 2 quarters · filed 2023-03-31 | $0.00 10-K · filed 2023-03-31 | $6.20M 10-K · filed 2021-03-31 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $6.20M 10-Q · filed 2021-11-15 | ||||
| 2020-07-07 | $6.10M 10-Q · filed 2020-11-09 | |||||
| 2020-06-30 | $6.20M 10-Q · filed 2021-08-16 | |||||
| 2018-09-30 | $43.00K 10-K · filed 2020-05-15 | |||||
| 2017-12-31 | $336.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $772.00 derived: sum of 2 quarters · filed 2019-03-15 | $13.60K derived: sum of 3 quarters · filed 2019-03-15 | $43.00K 10-K · filed 2019-03-15 | $42.66K 10-K · filed 2018-03-09 | |
| 2017-09-30 | $436.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $13.26K derived: sum of 2 quarters · filed 2018-11-08 | $42.66K 10-Q · filed 2018-11-08 | $67.66K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | $12.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $42.23K 10-Q · filed 2018-08-09 | $67.23K derived: sum of 3 quarters · filed 2018-08-09 | $67.23K derived: sum of 4 quarters · filed 2018-08-09 | ||
| 2017-03-31 | $29.40K 10-Q · filed 2018-05-11 | $54.40K derived: sum of 2 quarters · filed 2018-05-11 | $54.40K derived: sum of 3 quarters · filed 2018-05-11 | $121.04K derived: sum of 4 quarters · filed 2018-05-11 | ||
| 2016-12-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $25.00K derived: sum of 2 quarters · filed 2018-03-09 | $91.64K derived: sum of 3 quarters · filed 2018-03-09 | $111.74K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $66.64K derived: sum of 2 quarters · filed 2017-11-09 | $86.74K 10-Q · filed 2017-11-09 | $86.74K derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | $66.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $86.74K 10-Q · filed 2017-08-11 | $86.74K derived: sum of 3 quarters · filed 2017-08-11 | $86.74K derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $20.10K 10-Q · filed 2017-05-12 | $20.10K derived: sum of 2 quarters · filed 2017-05-12 | $20.10K derived: sum of 3 quarters · filed 2017-05-12 | $20.10K derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | ||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | |||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |